Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. 4. Sept. 2024 · Taipei, Taiwan - September 4, 2024 - Tanvex BioPharma, Inc. (“Tanvex” or “the Company”, TWSE: 6541), the biosimilar-focused biopharmaceutical company and CDMO, today announced that its Board of Directors has appointed Stephen Lam as the Company's Chief Executive Officer, effective September 5, 2024.

  2. 5. Sept. 2024 · Tanvex BioPharma has appointed Stephen Lam as Chief Executive Officer, effective September 5, 2024, as part of its ongoing strategic alliance with Bora Pharmaceuticals. Lam will oversee Tanvex’s global CDMO operations and biosimilar commercialization, bringing over 35 years of industry experience.

  3. Vor 14 Stunden · Foto: Stephen Lam / ASSOCIATED PRESS Die Oakland Athletics haben sich in der Major League Baseball (MLB) mit einem Sieg von ihrer langjährigen Heimat verabschiedet.

  4. 4. Sept. 2024 · Tanvex BioPharma Inc., the biosimilar-focused biopharmaceutical company and CDMO, has appointed Stephen Lam as its Chief Executive Officer, effective September 5, 2024. Lam succeeds Henry Chen, who will remain the Chairman until the closing of Tanvex’s strategic alliance with Bora Pharmaceuticals Co., Ltd.

  5. 5. Sept. 2024 · Tanvex BioPharma has appointed Stephen Lam as CEO, succeeding Henry Chen, who will remain chairman until Tanvex’s strategic alliance with Bora Pharmaceuticals is finalized.

  6. Stephen Lam. STANDARD: Die zweite große Säule neben Ernährung ist Sport. Aber auch das weiß man schon lange. Schulz: Genau, aber auch da gibt es jetzt viel klarere Zusammenhänge, etwa ...

  7. 5. Sept. 2024 · Tanvex BioPharma. A biosimilar-focused biopharmaceutical company and CDMO. Tanvex is a vertically-integrated company, with end-to-end capabilities from R&D through to commercialization. Cell line development and characterization, master cell selection and cell “seeds” are produced in the company’s Taiwan-based lab, while second ...